Carolyn Reimann

Carolyn Reimann, a woman-owned, service-disabled veteran-owned, and veteran-owned sole proprietorship based in Cabin John, Maryland, provides medical case review and expert witness services for federal vaccine injury compensation programs as a prime contractor exclusively under small-business set-asides. Reimann operates 100% as a prime (13 awards, zero subcontract work) and competes exclusively within the Health Resources and Services Administration (HRSA) for medical expert testimony and case evaluation services supporting the Vaccine Injury Compensation Program (VICP) and Countermeasures Injury Compensation Program (CICP).

Reimann's entire federal footprint is concentrated with a single customer: HRSA accounts for 100% of awards and combined potential value ($7.8 million across 13 awards). Her work is standardized and highly repetitive — all 13 awards fall under NAICS 541611 (Administrative Management and General Management Consulting Services) and PSC Support–Professional: Expert Witness, reflecting a narrow capability set focused on individual case review and expert testimony for specific vaccine injury claims. Work is performed at her Maryland location.

Reimann holds a single-award Blanket Purchase Agreement with HRSA valued at $7.5 million and running through April 19, 2028, awarded April 20, 2023. All 13 awards in her footprint are task order calls under this BPA vehicle, each typically valued between $10,150 and $24,500. Recent representative work includes a $24,500 firm-fixed-price task order awarded April 1, 2026, for medical case reviewer services on specific VICP cases (completion February 28, 2027), and a $24,500 task order awarded September 23, 2025, for CICP medical case review and expert witness testimony (completion August 22, 2026). Task orders span case-specific assignments, with individual orders naming four to six VICP or CICP case numbers per contract.

Activity patterns show irregularity: five awards in 2023, two in 2024, five in 2025, and one in 2026. Only three awards (combined potential value $71 thousand) reach ultimate completion within the next twenty-four months, suggesting limited near-term recompete exposure. Actual obligations total $270 thousand against combined potential value of $7.8 million (3% obligated), indicating task orders are drawn down incrementally as cases are assigned. Most awards carry total small business set-aside designations, though a subset use no set-aside.